|
May 27
|
ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
|
|
May 26
|
3 Reasons to Avoid ANIP and 1 Stock to Buy Instead
|
|
May 23
|
ANI Pharmaceuticals initiates Phase IV trial of gel for acute gout flares
|
|
May 23
|
1 Russell 2000 Stock with Solid Fundamentals and 2 to Steer Clear Of
|
|
May 23
|
Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers
|
|
Apr 25
|
Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season?
|
|
Apr 24
|
Zacks.com featured highlights include Heritage Insurance, Marex, Kingstone, ANI Pharmaceuticals and HCI
|
|
Apr 23
|
Zacks.com featured highlights include ANI Pharmaceuticals, Heritage Insurance, Avista and Exelon
|
|
Apr 23
|
5 Stocks With Recent Price Strength Amid Tariff-Led Volatility
|
|
Apr 22
|
4 Stocks Trading Near 52-Week High With Room to Rise Further
|
|
Apr 17
|
ANI Pharmaceuticals, Inc. (ANIP) Soars to 52-Week High, Time to Cash Out?
|
|
Apr 17
|
Pharmaceuticals Stocks Q4 In Review: Jazz Pharmaceuticals (NASDAQ:JAZZ) Vs Peers
|
|
Apr 15
|
ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q4 Earnings?
|
|
Apr 10
|
IBD 50 Stock Flashes 'Golden Cross' But Massive Risk Looms
|
|
Apr 10
|
VALN Doses First Infant With Shigella Vaccine in Mid-Stage Study
|
|
Apr 9
|
3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)
|
|
Apr 9
|
Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?
|
|
Apr 9
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
|
Apr 9
|
ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET
|
|
Apr 8
|
Zacks.com featured highlights ANI Pharmaceuticals, Expand Energy, Avista Corp and Contango ORE
|